The BD Prevue™ II Peripheral Vascular Access System reportedly offers real-time needle depth markers that may reduce multiple needlestick attempts and allow easier placement of intravenous (IV) access in high-risk patients.
Could an emerging ultrasound guidance modality make challenging IV (intravenous) access a thing of the past for hospitalized patients?
Recognizing the frequent challenges with vessel visualization and access for IV placement in hospitalized patients, BD (Becton, Dickinson and Company) has launched the BD Prevue™ II Peripheral Vascular Access System, an ultrasound guidance modality that may improve the efficiency and safety of needlesticks for IV access.
BD said key features of the BD Prevue II Vascular Access System include:
• real-time needle depth markers;
• a specialized probe, which allows use of the technology without the clinician altering his or her field of view or current insertion technique;
• a virtual display of the needle trajectory with BD Cue™ Needle Tracking Technology; and
• vessel assessment tools that help ensure optimal IV catheter length.
“Difficult IV access remains far too common today, but the availability of the BD Prevue II (Vascular Access) System supports a future where every needle stick has a predefined pathway for successful placement,” noted Eric Borin, the worldwide president of Medication Delivery Solutions at BD. “ … First-stick success also reduces the pain and anxiety patients often experience while undergoing multiple IV access attempts and provides clinicians with IV workflow efficiencies and confidence.”
BD added the BD Prevue Vascular Access System is compatible with BD Cue Needle Tracking-enabled catheters.
(Editor’s note: For a related article, see “Intravascular Ultrasound for Lower Extremity Interventions: Seven Takeaways for New Global Consensus Recommendations.”)
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.